SCHEMBL3628202

SCHEMBL3628202

O=C(O)c1ccccc1C(=O)OCc1ccccc1F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.63
KDM4E B2RXH2 2/20 0.63
LMNA P02545 2/20 0.63
NPC1 O15118 7/20 0.58
L3MBTL1 Q9Y468 5/20 0.58
TSHR P16473 2/20 0.58
GLA P06280 1/20 0.58
MMP1 P03956 1/20 0.54
MMP2 P08253 1/20 0.54
MMP9 P14780 1/20 0.54
MMP12 P39900 1/20 0.54
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
POLB P06746 1/20 0.52
MAPK1 P28482 1/20 0.52
MAPT P10636 2/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 2/20 0.49
ATM Q13315 1/20 0.48
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL3628198 0.94 ALDH1A1 (0.61) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL28084232 0.88 ALDH1A1 (0.73) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL3628696 0.80 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAL3MBTL1TDP1
SCHEMBL1790735 0.79 ALDH1A1 (0.56) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL11318013 0.78 ALDH1A1 (0.64) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL13685744 0.78 LMNA (0.53) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL29687907 0.78 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1TSHRMMP1
SCHEMBL116566 0.78 ALDH1A1 (1.00) ALDH1A1LMNAL3MBTL1TSHRMMP1
Phthalic Acid SCHEMBL3628205 0.78 ALDH1A1 (0.54) ALDH1A1KDM4ELMNANPC1L3MBTL1
SCHEMBL2451525 0.77 ALDH1A1 (0.68) ALDH1A1KDM4ELMNANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1935866-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL CENTRAL GLASS CO LTD (JP) 2011-12-14 EP disclosed
US-7795478-B2 Process for producing optically active fluorobenzyl alcohol CENTRAL GLASS COMPANY, LIMITED (JP) 2010-09-14 US disclosed
US-20090240087-A1 Process for Producing Optically Active Fluorobenzyl Alcohol CENTRAL GLASS COMPANY, LIMITED (JP) 2009-09-24 US disclosed
EP-1935866-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL Central Glass Company, Limited (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240087-A1 Process for Producing Optically Active Fluorobenzyl Alcohol ADH1A, ADH1C, ADH5 ALDH1A1 47/4885KDM4E 1056/4885LMNA 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.